DSHS Form 13-832 Tysabri (Natalizumab) J2323 Request - Washington

What Is DSHS Form 13-832?

This is a legal form that was released by the Washington State Department of Social and Health Services - a government authority operating within Washington. As of today, no separate filing guidelines for the form are provided by the issuing department.

FAQ

Q: What is DSHS Form 13-832?
A: DSHS Form 13-832 is a form used to request Tysabri (Natalizumab) J2323 in the state of Washington.

Q: What is Tysabri (Natalizumab) J2323?
A: Tysabri (Natalizumab) J2323 is a medication used to treat multiple sclerosis.

Q: Who can use DSHS Form 13-832?
A: DSHS Form 13-832 is used by healthcare providers in Washington to request Tysabri (Natalizumab) J2323 on behalf of their patients.

Q: Why is DSHS Form 13-832 required?
A: DSHS Form 13-832 is required to ensure that the use of Tysabri (Natalizumab) J2323 is appropriate and meets the necessary criteria.

Q: Are there any fees associated with DSHS Form 13-832?
A: No, there are no fees associated with submitting DSHS Form 13-832.

Q: How long does it take to process DSHS Form 13-832?
A: The processing time for DSHS Form 13-832 may vary, but it typically takes a few weeks.

Q: Are there any eligibility requirements for Tysabri (Natalizumab) J2323?
A: Yes, there are eligibility requirements for Tysabri (Natalizumab) J2323, and these are outlined on DSHS Form 13-832.

Q: Can I appeal a denial of Tysabri (Natalizumab) J2323?
A: Yes, if Tysabri (Natalizumab) J2323 is denied, you have the right to appeal the decision.